SubHero Banner

Flublok® Quadrivalent (influenza vaccine) – New formulation approval

October 7, 2016 – The FDA approved Protein Sciences Corporation’s Flublok Quadrivalent (influenza vaccine), for active immunization against disease caused by influenza A subtype viruses and type B viruses contained in the vaccine for use in persons 18 years of age and older.

Download PDF